Dr. Wang on Addition of Acalabrutinib to Bendamustine/Rituximab in MCL OncLive 1:07 4 years ago 169 Скачать Далее
Acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 249 Скачать Далее
Rationale for Combining Acalabrutinib With Bendamustine and Rituximab in MCL Targeted Oncology 1:14 5 years ago 208 Скачать Далее
Dr. Wang on the Toxicity of Ibrutinib, Acalabrutinib, and Zanubrutinib in MCL OncLive 1:10 4 years ago 938 Скачать Далее
Dr. Wang on Updated Data With Single-Agent Acalabrutinib in MCL OncLive 0:54 5 years ago 166 Скачать Далее
Safety and Efficacy Findings for Acalabrutinib Plus Bendamustine and Rituximab in MCL OncLive 1:51 5 years ago 203 Скачать Далее
Dr. Phillips on the Safety of Acalabrutinib Plus Bendamustine/Rituximab in MCL OncLive 1:06 5 years ago 103 Скачать Далее
Dr. Wang on Acalabrutinib Activity in Mantle Cell Lymphoma OncLive 2:20 6 years ago 2 033 Скачать Далее
Dr. Wang on Future Research With CAR T-Cell Therapy in MCL OncLive 1:01 3 years ago 146 Скачать Далее
Bendamustine/Rituximab as Induction Therapy in MCL Targeted Oncology 1:37 4 years ago 399 Скачать Далее
Dr. Wang on Triplet Vorinostat Regimen in Newly Diagnosed MCL OncLive 1:19 4 years ago 98 Скачать Далее
Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL OncLive 1:33 6 years ago 395 Скачать Далее
Dr. Patel on Induction Therapy With Bendamustine and Rituximab in MCL OncLive 1:35 5 years ago 990 Скачать Далее
Real-world data on previously untreated MCL in the US and the SHINE study VJHemOnc – Video Journal of Hematology & HemOnc 3:47 3 years ago 257 Скачать Далее